Å. Wasteson

发表

Partial purification and characterization of platelet factors stimulating the multiplication of normal human glial cells.

C. Heldin, B. Westermark, Å. Wasteson, 1977, Experimental Cell Research.

A platelet factor stimulating human normal glial cells.

B. Westermark, Å. Wasteson, 1976, Experimental cell research.

UVB radiation affects the mobility of epidermal growth factor receptors in human keratinocytes and fibroblasts

K. Magnusson, Å. Wasteson, M. Lirvall, 1996, Bioscience reports.

Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor

C. Heldin, B. Westermark, Å. Wasteson, 1982, Nature.

Surface binding and internalization of platelet-derived growth factor in human fibroblasts.

C. Heldin, J. Thyberg, B. Westermark, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Lateral diffusion of plasma membrane receptors labelled with either platelet-derived growth factor (PDGF) or wheat germ agglutinin (WGA) in human polymorphonuclear leukocytes and fibroblasts

K. Magnusson, Å. Wasteson, Pia Ljungquist, 1989, Bioscience reports.

Platelet-Derived Growth Factor: Mechanism of Action and Relation to Oncogenes

C. Heldin, C. Betsholtz, M. Nistér, 1985, Journal of Cell Science.

Platelet-derived growth factor: purification and partial characterization.

C. Heldin, B. Westermark, Å. Wasteson, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Demonstration of an antibody against platelet-derived growth factor.

C. Heldin, B. Westermark, Å. Wasteson, 1981, Experimental cell research.

Interaction of platelet-derived growth factor with its fibroblast receptor. Demonstration of ligand degradation and receptor modulation.

C. Heldin, B. Westermark, Å. Wasteson, 1982, The Journal of biological chemistry.

Storage and turnover of histamine, 5-hydroxytryptamine and heparin in rat peritoneal mast cells in vivo.

L. Enerbäck, Å. Wasteson, U. Wingren, 1983, International archives of allergy and applied immunology.

Synthesis of a PDGF-like growth factor in human glioma and sarcoma cells suggests the expression of the cellular homologue to the transforming protein of simian sarcoma virus.

C. Heldin, C. Betsholtz, M. Nistér, 1983, Biochemical and biophysical research communications.

A comparative study of glycosaminoglycans in cultures of human, normal and malignant glial cells

B. Westermark, B. Glimelius, Å. Wasteson, 1979, Journal of cellular physiology.

Composition and distribution of glycosaminoglycans in cultures of human normal and malignant glial cells.

B. Westermark, B. Glimelius, Å. Wasteson, 1978, The Biochemical journal.

Heparan sulfate proteoglycan of cultured cells: demonstration of a lipid- and a matrix-associated form.

B. Glimelius, Å. Wasteson, B. Norling, 1981, Biochemical and biophysical research communications.

Effect of a platelet endoglycosidase on cell surface associated heparan sulphate of human cultured endothelial and glial cells

C. Heldin, B. Westermark, B. Glimelius, 1977 .

Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides.

C. Heldin, A. Oldberg, M. Höök, 1980, Biochemistry.

Enzymatic depolymerization of heparin-related polysaccharides. Substrate specificities of mouse mastocytoma and human platelet endo-beta-D-glucuronidases.

H. C. Robinson, Å. Wasteson, U. Lindahl, 1982, The Journal of biological chemistry.

Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha and their receptors.

S. Wingren, T. Walz, Å. Wasteson, 1998, European journal of cancer.

Leukemia (hl-60) Cells Protooncogene in Differentiating Human Promyelocytic Α Expression of the Transforming Growth Factor Updated Version Citing Articles E-mail Alerts Expression of the Transforming Growth Factor a Protooncogene in Differentiating Human Promyelocytic Leukemia (hl-60) Cells'

T. Walz, Å. Wasteson, C. Malm, 2013 .

Platelet-derived growth factor. Isolation by a large-scale procedure and analysis of subunit composition.

C. Heldin, B. Westermark, Å. Wasteson, 1981, The Biochemical journal.

Desensitisation of cultured glial cells to epidermal growth factor by receptor down-regulation

C. Heldin, B. Westermark, Å. Wasteson, 1979, Nature.

Platelet-derived growth factor

C. Heldin, B. Westermark, Å. Wasteson, 1985, Molecular and Cellular Endocrinology.

CR3, FcγRIIA and FcγRIIIB induce activation of the respiratory burst in human neutrophils: the role of intracellular Ca2+, phospholipase D and tyrosine phosphorylation

Å. Wasteson, O. Stendahl, L. Serrander, 1999 .

Suramin inhibits growth of human osteosarcoma xenografts in nude mice.

S. Wingren, T. Walz, Å. Wasteson, 1991, Cancer research.

Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities

K. Bornfeldt, H. Arnqvist, Å. Wasteson, 1991, Diabetologia.

A PLATELET‐DERIVED GROWTH FACTOR ANALOG PRODUCED BY A HUMAN CLONAL GLIOMA CELL LINE *

C. Heldin, M. Nistér, B. Westermark, 1982, Annals of the New York Academy of Sciences.

Chemical and biological properties of a growth factor from human‐cultured osteosarcoma cells: Resemblance with platelet‐derived growth factor

C. Heldin, B. Westermark, Å. Wasteson, 1980, Journal of cellular physiology.

Purification of human platelet-derived growth factor.

C. Heldin, L. Rönnstrand, B. Westermark, 1987, Methods in enzymology.

A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity.

C. Heldin, M. Nistér, B. Westermark, 1984, Proceedings of the National Academy of Sciences of the United States of America.

The c‐sis gene encodes a precursor of the B chain of platelet‐derived growth factor.

P. Seeburg, A. Ullrich, C. Heldin, 1984, The EMBO journal.

COULD PLATELET-DERIVED GROWTH FACTOR HAVE A ROLE IN THE PATHOGENESIS OF LUPUS NEPHRITIS?

C. Heldin, G. Frampton, J. Cameron, 1988, The Lancet.

A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain.

U. Hellman, C. Heldin, B. Westermark, 1988, The Journal of biological chemistry.

Transforming growth factor (TGF beta) decreases the proliferation of human bone marrow fibroblasts by inhibiting the platelet-derived growth factor (PDGF) binding.

M. Bryckaert, M. Lindroth, G. Tobelem, 1988, Experimental cell research.

Production of transforming growth factor alpha by normal human blood eosinophils.

T. Walz, Å. Wasteson, C. Malm, 1993, Leukemia.

Uptake of 125I-PDGF-AB to the blood after extravascular administration in mice.

T. Walz, Å. Wasteson, A. Abdiu, 1998, Life sciences.

Release of a cell growth promoting factor from human platelets.

B. Westermark, Å. Wasteson, C. Busch, 1976, Thrombosis research.

Binding of platelet factor 4 to cultured human umbilical vein endothelial cells.

D. Pepper, Å. Wasteson, J. Dawes, 1980, Thrombosis research.

Demonstration of a platelet enzyme, degrading heparan sulphate

B. Westermark, M. Höök, Å. Wasteson, 1976, FEBS letters.

Lateral diffusion of PDGF beta-receptors in human fibroblasts.

K. Magnusson, Å. Wasteson, M. Lirvall, 1991, Bioscience reports.

Transforming growth factor-alpha (TGF-alpha) in human bone marrow: demonstration of TGF-alpha in erythroblasts and eosinophilic precursor cells and of epidermal growth factor receptors in blastlike cells of myelomonocytic origin.

T. Walz, Å. Wasteson, C. Malm, 1994, Blood.

Ammonium ion interferes with the lysosomal degradation of glycosaminoglycans in cultures of human glial cells.

B. Westermark, B. Glimelius, Å. Wasteson, 1977, Experimental cell research.

The response of cultured human normal glial cells to growth factors.

B. Westermark, Å. Wasteson, 1975, Advances in metabolic disorders.

Somatomedin B: mitogenic activity derived from contaminant epidermal growth factor.

C. Heldin, B. Westermark, Å. Wasteson, 1981, Science.

Megakaryocytes and myelofibrosis in gray platelet syndrome.

M. Bryckaert, E. Dupuy, Å. Wasteson, 1987, Nouvelle revue francaise d'hematologie.

Production of transforming growth factor alpha by human leukemia cells (HL-60 and U-937) during monocytic differentiation.

S. Wingren, T. Walz, Å. Wasteson, 1995, Leukemia.

Pure Platelet-Derived Growth Factor Stimulates Human Fibroblasts to Proliferate in Plasma-Free Culture

C. Heldin, C. Betsholtz, B. Westermark, 1983 .

The effect of growth factors and synovial fluid on chondrogenesis in perichondrium.

Å. Wasteson, V. Skoog, L. Ohlsén, 1990, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

Targeting malignant glioma cells in vitro using platelet-derived growth factor AA-based conjugates

Å. Wasteson, A. Lindström, M. Wester, 2009, Journal of drug targeting.

Collagen-induced binding to human platelets of platelet-derived growth factor leading to inhibition of P43 and P20 phosphorylation.

M. Bryckaert, F. Rendu, G. Tobelem, 1989, The Journal of biological chemistry.

Expression of the transforming growth factor alpha protooncogene in differentiating human promyelocytic leukemia (HL-60) cells.

T. Walz, Å. Wasteson, C. Malm, 1993, Cancer research.

Transforming growth factor alpha expression in normal human blood eosinophils: differential regulation by granulocyte-macrophage colony-stimulating factor and interleukin-3.

T. Walz, Å. Wasteson, C. Malm, 1994, Leukemia.

Both Intra- and Extracellular Ca2+ Participate in the Regulation of the Lateral Diffusion of the PDGF-β2 Receptor

K. Magnusson, V. Loitto, Å. Wasteson, 2000, Bioscience reports.

A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate.

Å. Wasteson, 1971, Journal of chromatography.

Interleukin-6 Enhances Transforming Growth Factor-alpha mRNA Expression in Macrophage-Like Human Monocytoid (U-937-1) Cells

T. Walz, Å. Wasteson, A. Hallbeck, 2001, Bioscience reports.

A chondroitin sulphate proteoglycan from human cultured glial and glioma cells. Structural and functional properties.

B. Glimelius, Å. Wasteson, B. Norling, 1984, The Biochemical journal.

A chondroitin sulphate proteoglycan from human cultured glial cells aggregates with hyaluronic acid.

B. Westermark, B. Glimelius, Å. Wasteson, 1978, Biochemical and biophysical research communications.

Growth Factor Release during Preparation and Storage of Platelet Concentrates

G. Berlin, Å. Wasteson, E. Ledent, 1995, Vox sanguinis.

Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells?

A. Engström‐Làurent, R. Hällgren, N. Feltelius, 1985, Annals of the rheumatic diseases.

Aggregation of feline lymphoma cells by hyaluronic acid

J. Pontén, B. Westermark, Å. Wasteson, 1973, International journal of cancer.

Suramin blocks growth-stimulatory effects of platelet-derived growth factor on malignant fibrous histiocytomas in vitro.

T. Walz, Å. Wasteson, A. Abdiu, 1999, Cancer letters.

A novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effects of somatomedin on cultured cells.

B. Westermark, Å. Wasteson, K. Uthne, 1973, The Biochemical journal.

A heparan sulfate-degrading endoglycosidase from rat liver tissue.

A. Oldberg, M. Höök, Å. Wasteson, 1975, Biochemical and biophysical research communications.

Properties of fractionated chondroitin sulphate from ox nasal septa.

Å. Wasteson, 1971, The Biochemical journal.

Biosynthesis of chondroitin sulphate in cartilage regenerated from perichondrium.

Å. Wasteson, L. Ohlsén, 1977, Scandinavian journal of plastic and reconstructive surgery.

Degradation of Chondroitin Sulphate by Lysosomal Enzymes from Embryonic Chick Cartilage

R. Amadó, Å. Wasteson, C. Heldin, 1975 .

Growth of normal human glial cells in a defined medium containing platelet-derived growth factor.

C. Heldin, B. Westermark, Å. Wasteson, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus

Paul Stroobant, C. Heldin, M. Waterfield, 1983, Nature.

Molecular size and xylose content of urinary glycosaminoglycans.

Å. Wasteson, E. Wessler, 1971, Biochimica et biophysica acta.

A method for the determination of molecular weight dispersion in chondroitin sulphate on a microgram level.

Å. Wasteson, 1969, Biochimica et biophysica acta.

Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia.

C. Heldin, B. Westermark, Å. Wasteson, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Biosynthesis of heparin. Solubilization and partial characterization of N- and O-sulphotransferases.

M. Höök, Å. Wasteson, U. Lindahl, 1975, The Biochemical journal.

Turnover of cell surface associated glycosaminoglycans in cultures of human normal and malignant glial cells.

B. Westermark, Å. Wasteson, B. Norling, 1978, Experimental cell research.

Nature of the interaction of chondroitin 4-sulphate and chondroitin sulphate-proteoglycan with collagen.

B. Obrink, Å. Wasteson, 1971, The Biochemical journal.

Initiation of DNA synthesis of stationary human glia-like cells by a polypeptide fraction from human plasma containing somatomedin activity.

B. Westermark, Å. Wasteson, K. Uthne, 1975, Experimental cell research.

Accumulation of Boron in Human Malignant Glioma Cells in vitro is Cell Type Dependent

J. Capala, Å. Wasteson, A. Lindström, 2004, Journal of Neuro-Oncology.

Platelet contribution to cancer cell growth and migration: the role of platelet growth factors.

E. Vicenzi, Å. Wasteson, A. Poggi, 1988, Haemostasis.

Effects of human platelet-derived growth factor-AB on sarcoma growth in vitro and in vivo.

S. Wingren, T. Walz, Å. Wasteson, 1999, Cancer letters.

Somatomedin A and B: demonstration of two different somatomedinlike components in human plasma.

B. Westermark, Å. Wasteson, K. Uthne, 1975, Advances in metabolic disorders.

Cell surface components and growth regulation in cultivated arterial smooth muscle cells.

J. Thyberg, Å. Wasteson, J. Nilsson, 1983, Journal of cell science.

Platelet-derived growth factor: identification of constituent polypeptide chains.

C. Heldin, B. Westermark, Å. Wasteson, 1982, Biochemical and biophysical research communications.

Iduronate sulfatase from human plasma.

E. Neufeld, Å. Wasteson, 1982, Methods in enzymology.

TGF‐α and ErbB2 production in synovial joint tissue: increased expression in arthritic joints

T. Walz, Å. Wasteson, K. Briheim, 2005, Scandinavian journal of rheumatology.

Demonstration of an interaction between collagen and chondroitin sulphate.

B. Obrink, Å. Wasteson, 1968, Biochimica et Biophysica Acta.

Mode of degradation of the chondroitin sulphate proteoglycan in rat costal cartilage.

Å. Wasteson, U. Lindahl, A. Hallén, 1972, The Biochemical journal.

Formation of chondroitin sulphate proteoglycan in cartilage regenerated from free perichondrial graft.

Å. Wasteson, L. Ohlsén, B. Widenfalk, 1989, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

The molecular weight of chondroitin sulphate from human articular cartilage

Å. Wasteson, S. Hjertquist, 1972, Calcified Tissue Research.

Working collaboratively to support medical education in developing countries: the case of the Friends of Moi University Faculty of Health Sciences.

R. Einterz, G. Majoor, Å. Wasteson, 2007, Education for health.

Lateral diffusion of PDGF β-receptors in human fibroblasts

K. Magnusson, Å. Wasteson, M. Lirvall, 1991 .

CR3, FcgammaRIIA and FcgammaRIIIB induce activation of the respiratory burst in human neutrophils: the role of intracellular Ca(2+), phospholipase D and tyrosine phosphorylation.

Å. Wasteson, O. Stendahl, L. Serrander, 1999, Biochimica et biophysica acta.

Sequential degradation of a chondroitin sulphate trisaccharide by lysosomal enzymes from embryonic-chick epiphysial cartilage.

Å. Wasteson, B. Ingmar, 1979, The Biochemical journal.